Skip to main content
Log in

Guanosine prevents nitroxidative stress and recovers mitochondrial membrane potential disruption in hippocampal slices subjected to oxygen/glucose deprivation

  • Original Article
  • Published:
Purinergic Signalling Aims and scope Submit manuscript

Abstract

Guanosine, the endogenous guanine nucleoside, prevents cellular death induced by ischemic events and is a promising neuroprotective agent. During an ischemic event, nitric oxide has been reported to either cause or prevent cell death. Our aim was to evaluate the neuroprotective effects of guanosine against oxidative damage in hippocampal slices subjected to an in vitro ischemia model, the oxygen/glucose deprivation (OGD) protocol. We also assessed the participation of nitric oxide synthase (NOS) enzymes activity on the neuroprotection promoted by guanosine. Here, we showed that guanosine prevented the increase in ROS, nitric oxide, and peroxynitrite production induced by OGD. Moreover, guanosine prevented the loss of mitochondrial membrane potential in hippocampal slices subjected to OGD. Guanosine did not present an antioxidant effect per se. The protective effects of guanosine were mimicked by inhibition of neuronal NOS, but not of inducible NOS. The neuroprotective effect of guanosine may involve activation of cellular mechanisms that prevent the increase in nitric oxide production, possibly via neuronal NOS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Abbreviations

1400 W:

N-(3-(Aminomethyl)benzyl)acetamidine

7-NI:

7-nitroindazole

eNOS:

Endothelial nitric oxide synthase

GUO:

Guanosine

HBSS:

Hank’s balanced salt solution

iNOS:

Inducible nitric oxide synthase

KRB:

Krebs-Ringer bicarbonate buffer

L-NAME:

L-N G-nitro-L-arginine methyl ester

MTT:

3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide

nNOS:

Neuronal nitric oxide synthase

OGD:

Oxygen/glucose deprivation

ONOO :

Peroxynitrite

ROS:

reactive oxygen species

References

  1. Brouns R, De Deyn PP (2009) The complexity of neurobiological processes in acute ischemic stroke. Clin Neurol Neurosurg 111(6):483–95

    Article  CAS  PubMed  Google Scholar 

  2. Donnan GA et al (2008) Stroke. Lancet 371(9624):1612–23

    Article  CAS  PubMed  Google Scholar 

  3. Carden DL, Granger DN (2000) Pathophysiology of ischaemia-reperfusion injury. J Pathol 190(3):255–66

    Article  CAS  PubMed  Google Scholar 

  4. Bolanos JP et al (2009) Mitochondria and reactive oxygen and nitrogen species in neurological disorders and stroke: therapeutic implications. Adv Drug Deliv Rev 61(14):1299–315

    Article  CAS  PubMed  Google Scholar 

  5. Connell BJ et al (2013) Guanosine protects against reperfusion injury in rat brains after ischemic stroke. J Neurosci Res 91(2):262–72

    Article  CAS  PubMed  Google Scholar 

  6. Nanetti L et al (2011) Oxidative stress in ischaemic stroke. Eur J Clin Investig 41(12):1318–22

    Article  CAS  Google Scholar 

  7. Moro MA et al (2004) Role of nitric oxide after brain ischaemia. Cell Calcium 36(3–4):265–75

    Article  CAS  PubMed  Google Scholar 

  8. Brown GC (2010) Nitric oxide and neuronal death. Nitric Oxide 23(3):153–65

    Article  CAS  PubMed  Google Scholar 

  9. Bolanos JP, Heales SJ (2010) Persistent mitochondrial damage by nitric oxide and its derivatives: neuropathological implications. Front Neuroenerg 2:1

    CAS  Google Scholar 

  10. Kovacs R et al (2009) Endogenous nitric oxide is a key promoting factor for initiation of seizure-like events in hippocampal and entorhinal cortex slices. J Neurosci 29(26):8565–77

    Article  CAS  PubMed  Google Scholar 

  11. Chang R et al (2008) Neuroprotective effects of guanosine on stroke models in vitro and in vivo. Neurosci Lett 431(2):101–5

    Article  CAS  PubMed  Google Scholar 

  12. Lanznaster D et al (2016) Guanosine: a neuromodulator with therapeutic potential in aging-related disorders. Aging Dis 7:5

    Google Scholar 

  13. Uemura Y et al (1991) Neurochemical analysis of focal ischemia in rats. Stroke 22(12):1548–53

    Article  CAS  PubMed  Google Scholar 

  14. Dal-Cim T et al (2011) Guanosine is neuroprotective against oxygen/glucose deprivation in hippocampal slices via large conductance Ca(2) + −activated K+ channels, phosphatidilinositol-3 kinase/protein kinase B pathway activation and glutamate uptake. Neuroscience 183:212–20

    Article  CAS  PubMed  Google Scholar 

  15. Dal-Cim T et al (2016) Neuroprotection promoted by guanosine depends on glutamine synthetase and glutamate transporters activity in hippocampal slices subjected to oxygen/glucose deprivation. Neurotox Res 29(4):460–8

    Article  CAS  PubMed  Google Scholar 

  16. Oliveira IJ et al (2002) Neuroprotective effect of GMP in hippocampal slices submitted to an in vitro model of ischemia. Cell Mol Neurobiol 22(3):335–44

    Article  CAS  PubMed  Google Scholar 

  17. Pocock JM, Nicholls DG (1998) Exocytotic and nonexocytotic modes of glutamate release from cultured cerebellar granule cells during chemical ischaemia. J Neurochem 70(2):806–13

    Article  CAS  PubMed  Google Scholar 

  18. Strasser U, Fischer G (1995) Quantitative measurement of neuronal degeneration in organotypic hippocampal cultures after combined oxygen/glucose deprivation. J Neurosci Methods 57(2):177–86

    Article  CAS  PubMed  Google Scholar 

  19. Trotti D, Danbolt NC, Volterra A (1998) Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration? Trends Pharmacol Sci 19(8):328–34

    Article  CAS  PubMed  Google Scholar 

  20. Liu Y et al (1997) Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J Neurochem 69(2):581–93

    Article  CAS  PubMed  Google Scholar 

  21. Noraberg J, Kristensen BW, Zimmer J (1999) Markers for neuronal degeneration in organotypic slice cultures. Brain Res Brain Res Protoc 3(3):278–90

    Article  CAS  PubMed  Google Scholar 

  22. Pringle AK et al (1996) Selective N-type calcium channel antagonist omega conotoxin MVIIA is neuroprotective against hypoxic neurodegeneration in organotypic hippocampal-slice cultures. Stroke 27(11):2124–30

    Article  CAS  PubMed  Google Scholar 

  23. Ferreira AG et al (2012) Experimental hyperprolinemia induces mild oxidative stress, metabolic changes, and tissue adaptation in rat liver. J Cell Biochem 113(1):174–83

    Article  CAS  PubMed  Google Scholar 

  24. Hernanz R et al (2008) Ouabain treatment increases nitric oxide bioavailability and decreases superoxide anion production in cerebral vessels. J Hypertens 26(10):1944–54

    Article  CAS  PubMed  Google Scholar 

  25. Yang Y et al (2004) Nitric oxide spatial distribution in single cultured hippocampus neurons: investigation by projection of reconstructed 3-D image and visualization technique. Cell Biol Int 28(8–9):577–83

    Article  CAS  PubMed  Google Scholar 

  26. Kooy NW et al (1994) Peroxynitrite-mediated oxidation of dihydrorhodamine 123. Free Radic Biol Med 16(2):149–56

    Article  CAS  PubMed  Google Scholar 

  27. Brandwilliams W, Cuvelier ME, Berset C (1995) Use of a free-radical method to evaluate antioxidant activity. Food Sci Technol Lebensmwiss Technol 28(1):25–30

    CAS  Google Scholar 

  28. Colle D et al (2012) Antioxidant properties of Taraxacum officinale leaf extract are involved in the protective effect against hepatoxicity induced by acetaminophen in mice. J Med Food 15(6):549–56

    Article  PubMed  Google Scholar 

  29. Green LC et al (1982) Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126(1):131–8

    Article  CAS  PubMed  Google Scholar 

  30. Ehrenberg B et al (1988) Membrane potential can be determined in individual cells from the nernstian distribution of cationic dyes. Biophys J 53(5):785–94

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Lorrio S et al (2013) Novel multitarget ligand ITH33/IQM9.21 provides neuroprotection in in vitro and in vivo models related to brain ischemia. Neuropharmacology 67:403–11

    Article  CAS  PubMed  Google Scholar 

  32. Perry SW et al (2011) Mitochondrial membrane potential probes and the proton gradient: a practical usage guide. Biotechniques 50(2):98–115

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Dal-Cim T et al (2013) Guanosine controls inflammatory pathways to afford neuroprotection of hippocampal slices under oxygen and glucose deprivation conditions. J Neurochem 126(4):437–50

    Article  CAS  PubMed  Google Scholar 

  34. Molz S et al (2011) Neuroprotective effect of guanosine against glutamate-induced cell death in rat hippocampal slices is mediated by the phosphatidylinositol-3 kinase/Akt/glycogen synthase kinase 3beta pathway activation and inducible nitric oxide synthase inhibition. J Neurosci Res 89(9):1400–8

    Article  CAS  PubMed  Google Scholar 

  35. Cardenas A et al (1998) Protective effect of N-(3-(aminomethyl)benzyl) acetamidine, an inducible nitric oxide synthase inhibitor, in brain slices exposed to oxygen-glucose deprivation. Eur J Pharmacol 354(2–3):161–5

    Article  CAS  PubMed  Google Scholar 

  36. Thauerer B, Zur Nedden S, Baier-Bitterlich G (2012) Purine nucleosides: endogenous neuroprotectants in hypoxic brain. J Neurochem 121(3):329–42

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Lara DR et al (2001) Effect of orally administered guanosine on seizures and death induced by glutamatergic agents. Brain Res 912(2):176–80

    Article  CAS  PubMed  Google Scholar 

  38. Schmidt AP, Lara DR, Souza DO (2007) Proposal of a guanine-based purinergic system in the mammalian central nervous system. Pharmacol Ther 116(3):401–16

    Article  CAS  PubMed  Google Scholar 

  39. Ribeiro FF et al (2016) Purine nucleosides in neuroregeneration and neuroprotection. Neuropharmacology 104:226–42

    Article  CAS  PubMed  Google Scholar 

  40. Dal-Cim T et al (2012) Guanosine protects human neuroblastoma SH-SY5Y cells against mitochondrial oxidative stress by inducing heme oxigenase-1 via PI3K/Akt/GSK-3beta pathway. Neurochem Int 61(3):397–404

    Article  CAS  PubMed  Google Scholar 

  41. Traversa U et al (2002) Specific [(3)H]-guanosine binding sites in rat brain membranes. Br J Pharmacol 135(4):969–76

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Volpini R et al (2011) Evidence for the existence of a specific g protein-coupled receptor activated by guanosine. ChemMedChem 6(6):1074–80

    Article  CAS  PubMed  Google Scholar 

  43. Schmidt AP et al (2008) Guanosine and its modulatory effects on the glutamatergic system. Eur Neuropsychopharmacol 18(8):620–2

    Article  CAS  PubMed  Google Scholar 

  44. Jackson EK et al (2013) Extracellular guanosine regulates extracellular adenosine levels. Am J Physiol Cell Physiol 304(5):C406–21

    Article  CAS  PubMed  Google Scholar 

  45. Hansel G et al (2014) The potential therapeutic effect of guanosine after cortical focal ischemia in rats. PLoS ONE 9(2):e90693

    Article  PubMed  PubMed Central  Google Scholar 

  46. Quincozes-Santos A et al (2014) Guanosine protects C6 astroglial cells against azide-induced oxidative damage: a putative role of heme oxygenase 1. J Neurochem 130(1):61–74

    Article  CAS  PubMed  Google Scholar 

  47. Cossenza M et al (2014) Nitric oxide in the nervous system: biochemical, developmental, and neurobiological aspects. Vitam Horm 96:79–125

    Article  CAS  PubMed  Google Scholar 

  48. Iadecola C (1997) Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 20(3):132–9

    Article  CAS  PubMed  Google Scholar 

  49. Nagafuji T et al (1995) Nitric oxide synthase in cerebral ischemia. Possible contribution of nitric oxide synthase activation in brain microvessels to cerebral ischemic injury. Mol Chem Neuropathol 26(2):107–57

    Article  CAS  PubMed  Google Scholar 

  50. Endres M et al (2004) Targeting eNOS for stroke protection. Trends Neurosci 27(5):283–9

    Article  CAS  PubMed  Google Scholar 

  51. Terpolilli NA, Moskowitz MA, Plesnila N (2012) Nitric oxide: considerations for the treatment of ischemic stroke. J Cereb Blood Flow Metab 32(7):1332–46

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Huang Z et al (1994) Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265(5180):1883–5

    Article  CAS  PubMed  Google Scholar 

  53. Vannucchi MG et al (2007) Relationships between neurons expressing neuronal nitric oxide synthase, degree of microglia activation and animal survival. A study in the rat cortex after transient ischemia. Brain Res 1132(1):218–27

    Article  CAS  PubMed  Google Scholar 

  54. Iijima T et al (2003) Mitochondrial membrane potential and intracellular ATP content after transient experimental ischemia in the cultured hippocampal neuron. Neurochem Int 43(3):263–9

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Research supported by grants from the Brazilian funding agencies to C.I.T.: CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico)–Projects IBN-Net # 01.06.0842-00 and INCT for Excitotoxicity and Neuroprotection; CAPES (Coordenação do Pessoal de Ensino Superior)–Project CAPES-PVE 052/2012; FAPESC (Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina)–Project NENASC. C.I.T. is a recipient of CNPq productivity fellowship and M.P.C. is a recipient of CAPES/PNPD post-doctoral scholarship. The authors state no conflicts of interest. All authors have materially participated in the research and/or article preparation.

Compliance with ethical standards

The procedures used in the present study complied with the guidelines on animal care of the UFSC Ethics Committee on the Use of Animals (CEUA), which follows the “Principles of laboratory animal care” from NIH (2011).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carla I. Tasca.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Thomaz, D.T., Dal-Cim, T.A., Martins, W.C. et al. Guanosine prevents nitroxidative stress and recovers mitochondrial membrane potential disruption in hippocampal slices subjected to oxygen/glucose deprivation. Purinergic Signalling 12, 707–718 (2016). https://doi.org/10.1007/s11302-016-9534-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11302-016-9534-3

Keywords

Navigation